These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14388010)

  • 1. Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers.
    SABIN AB
    Am J Med Sci; 1955 Jul; 230(1):1-8. PubMed ID: 14388010
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavior of chimpanzee-avirulent poliomyelitis viruses in experimentally infected human volunteers.
    SABIN AB
    Trans Assoc Am Physicians; 1955; 68():64-72. PubMed ID: 13299312
    [No Abstract]   [Full Text] [Related]  

  • 3. Poliovirus in chimpanzee tissues after virus feeding.
    BODIAN D
    Am J Hyg; 1956 Sep; 64(2):181-97. PubMed ID: 13362230
    [No Abstract]   [Full Text] [Related]  

  • 4. The recovery of poliomyelitis virus from the stools of experimentally infected monkeys and chimpanzees.
    MELNICK JL
    J Immunol; 1946 Jul; 53(3):277-90. PubMed ID: 20992664
    [No Abstract]   [Full Text] [Related]  

  • 5. The recovery of poliomyelitis virus from the stools of monkeys and chimpanzees experimentally infected by various routes.
    MELNICK JL
    Fed Proc; 1946; 5(1 Pt 2):250. PubMed ID: 21064605
    [No Abstract]   [Full Text] [Related]  

  • 6. Poliomyelitis virus in blood of orally infected monkeys and chimpanzees.
    HORSTMANN DM
    Proc Soc Exp Biol Med; 1952 Mar; 79(3):417-9. PubMed ID: 14920447
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of poliovirus in feces of chimpanzees during late convalescence by means of freon 113.
    HOWE HA
    Proc Soc Exp Biol Med; 1962 May; 110():110-3. PubMed ID: 14036386
    [No Abstract]   [Full Text] [Related]  

  • 8. Destruction of poliovirus in the digestive tract of chimpanzees by means of specific high-titre gamma-globulin.
    JEZIERSKI A
    Ann Soc Belg Med Trop (1920); 1960 Feb; 40():169-81. PubMed ID: 14407261
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral administration of a rodent-adapted strain of poliomyelitis virus to chimpanzees.
    KOPROWSKI H; JERVIS GA; NORTON TW
    Arch Gesamte Virusforsch; 1954; 5(5):413-24. PubMed ID: 13218593
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus.
    KOPROWSKI H; JERVIS GA; NORTON TW
    Am J Hyg; 1952 Jan; 55(1):108-24. PubMed ID: 14885170
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types.
    SABIN AB; HENNESSEN WA; WINSSER J
    J Exp Med; 1954 Jun; 99(6):551-76. PubMed ID: 13163327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in chimpanzees.
    BODIAN D; NATHANSON N
    Bull Johns Hopkins Hosp; 1960 Sep; 107():143-62. PubMed ID: 13801930
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus.
    SABIN AB
    Ann N Y Acad Sci; 1955 Sep; 61(4):1050-6. PubMed ID: 13340614
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclinical poliomyelitis in the chimpanzee and its relation to alimentary reinfection.
    HOWE HA; BODIAN D; MORGAN IM
    Am J Hyg; 1950 Jan; 51(1):85-108, tab. PubMed ID: 15401866
    [No Abstract]   [Full Text] [Related]  

  • 15. Behaviour of Chimpanzee-avirulent Poliomyelitis Viruses in Experimentally Infected Human Volunteers.
    Sabin AB
    Br Med J; 1955 Jul; 2(4932):160-2. PubMed ID: 20788449
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies.
    MELNICK JL; KAPLAN AS
    J Exp Med; 1953 Mar; 97(3):367-400. PubMed ID: 13052807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological properties of ribonucleic acid from virulent and attenuated poliovirus.
    GERBER P; KIRSCHSTEIN R
    J Exp Med; 1960 Apr; 111(4):525-32. PubMed ID: 13704559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
    Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
    Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The elimination of viruses by fecal matter in an institution of children infected with type 1 poliomyelitis virus].
    BETZ A
    Bull Soc Sci Med Grand Duche Luxemb; 1961 Oct; 98():415-22. PubMed ID: 13868679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.